Dr. Salman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nicolls Rd
Stony Brook, NY 11794
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
- Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
- University of Jordan Faculty of MedicineClass of 1991
Certifications & Licensure
- IN State Medical License 2021 - 2025
- NY State Medical License 2015 - 2022
- GA State Medical License 2013 - 2016
- VA State Medical License 2011 - 2014
- OH State Medical License 2009 - 2012
- TN State Medical License 2005 - 2007
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014, 2017-2018
Clinical Trials
- CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Publications & Presentations
PubMed
- 140 citationsPreclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptorKevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, K. W. Lin
Leukemia. 2017-01-12 - 55 citationsA phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML, or AML with ⩽ 30% blasts.G. Garcia-Manero, Mikkael A. Sekeres, Miklos Egyed, Massimo Breccia, Carlos Graux
Leukemia. 2017-05-26 - 59 citationsA compound chimeric antigen receptor strategy for targeting multiple myeloma.Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, Xiao Shuai
Leukemia. 2018-02-01
Journal Articles
- SALL1 expression in acute myeloid leukemiaiao Shuai,2,3,* Anh Thu Nguyen-Lefebvre,1,* Banabihari Giri,1 Mingqiang Ren,1 Michael Rauchman,4 Lynn Robbins,4 Wei Hou,2 Hasan Korkaya,1 and Yupo Ma2, Oncotarget, 1/26/2018
Press Mentions
- Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New YorkJuly 13th, 2021
- First in-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to Be LaunchedAugust 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: